Physician profile
Lauren Kyle Eaker
NPI 1629792312
$1,014.96
in general payments reported to CMS, 2019-2025
22 companies · $195 in 2025
The $195 reported for 2025 was more than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $12.92 · 2023: $263 · 2024: $544 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,002.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,002.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $183.08 | 2024 | |
| Novo Nordisk INC | $89.42 | 2023-2024 | Wegovy, Rybelsus, Ozempic |
| Dexcom, INC. | $83.18 | 2023-2024 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals LP | $81.30 | 2023-2024 | Farxiga, Airsupra, Breztri |
| Exact Sciences Corporation | $70.76 | 2023-2024 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $68.60 | 2025 | Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $59.50 | 2023-2024 | |
| Lilly USA, LLC | $53.77 | 2023-2024 | Mounjaro |
| Boston Scientific Corporation | $45.61 | 2024-2025 | Ams 700, Lumenis Pulse 120h |
| Endo USA, INC. | $43.14 | 2025 | Xiaflex, Aveed |
| Coloplast Corp | $29.52 | 2024-2025 | |
| 180 Medical, INC. | $25.32 | 2024 | |
| Janssen Biotech, INC. | $24.58 | 2025 | Erleada |
| Abbvie INC. | $22.52 | 2024 | |
| Philips North America LLC | $20.11 | 2024 | (Ck7) Extended Holter |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $18.25 | 2023 | Shingrix, Arexvy, Trelegy Ellipta |
| Amgen INC. | $18.00 | 2023 | Evenity, Prolia |
| Progenics Pharmaceuticals, INC. | $17.86 | 2024 | |
| Phathom Pharmaceuticals, INC. | $17.02 | 2024 | Voquezna |
| Urogen Pharma, INC. | $16.00 | 2025 | |
| Inspire Medical Systems, INC. | $14.50 | 2024 | Inspire |
| Merck Sharp & Dohme LLC | $12.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Eaker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.